{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,19]],"date-time":"2026-10-19T12:04:48Z","timestamp":1792411488827,"version":"4.4.0"},"reference-count":49,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,2,1]],"date-time":"2026-02-01T00:00:00Z","timestamp":1769904000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,2,1]],"date-time":"2026-02-01T00:00:00Z","timestamp":1769904000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,2,1]],"date-time":"2026-02-01T00:00:00Z","timestamp":1769904000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,2,1]],"date-time":"2026-02-01T00:00:00Z","timestamp":1769904000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,2,1]],"date-time":"2026-02-01T00:00:00Z","timestamp":1769904000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,2,1]],"date-time":"2026-02-01T00:00:00Z","timestamp":1769904000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,2,1]],"date-time":"2026-02-01T00:00:00Z","timestamp":1769904000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/100016976","name":"Fukushima Prefecture","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100016976","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Vaccine"],"published-print":{"date-parts":[[2026,2]]},"DOI":"10.1016\/j.vaccine.2025.128167","type":"journal-article","created":{"date-parts":[[2025,12,30]],"date-time":"2025-12-30T10:26:11Z","timestamp":1767090371000},"page":"128167","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":3,"special_numbering":"C","title":["Adverse events post-BNT162b2 vaccination in Japanese children"],"prefix":"10.1016","volume":"73","author":[{"given":"Hisao","family":"Okabe","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Koichi","family":"Hashimoto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuichiro","family":"Asano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Masatoki","family":"Sato","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hideyuki","family":"Nakatsu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takashi","family":"Ono","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yasuko","family":"Shibukawa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nobuko","family":"Sakai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Noriko","family":"Onishi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shinichi","family":"Oda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tsutomu","family":"Ishii","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Masaki","family":"Ito","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mikako","family":"Watanabe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yukihiko","family":"Watanabe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shigeo","family":"Suzuki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hideko","family":"Aoki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hiroko","family":"Sakuma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hayato","family":"Go","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mitsuaki","family":"Hosoya","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.vaccine.2025.128167_bb0005","doi-asserted-by":"crossref","first-page":"1097","DOI":"10.1093\/jpids\/piab085","article-title":"Clinical characteristics of hospitalized COVID-19 in children: report from the COVID-19 registry in Japan","volume":"10","author":"Shoji","year":"2021","journal-title":"J Pediatric Infect Dis Soc"},{"key":"10.1016\/j.vaccine.2025.128167_bb0010","doi-asserted-by":"crossref","first-page":"21450","DOI":"10.1038\/s41598-023-48904-w","article-title":"Therapeutic interventions and the length of hospital stay for pediatric patients with COVID-19: a multicenter cohort study","volume":"13","author":"Ishihara","year":"2023","journal-title":"Sci Rep"},{"key":"10.1016\/j.vaccine.2025.128167_bb0015","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1016\/j.pcl.2020.07.014","article-title":"Risk factors for severity in children with coronavirus disease 2019: a comprehensive literature review","volume":"68","author":"Tsabouri","year":"2021","journal-title":"Pediatr Clin North Am"},{"key":"10.1016\/j.vaccine.2025.128167_bb0020","doi-asserted-by":"crossref","DOI":"10.1016\/j.jns.2024.122867","article-title":"Clinical characteristics of SARS-CoV-2-associated encephalopathy in children: Nationwide epidemiological study","volume":"457","author":"Kasai","year":"2024","journal-title":"J Neurol Sci"},{"key":"10.1016\/j.vaccine.2025.128167_bb0025","doi-asserted-by":"crossref","first-page":"533","DOI":"10.3390\/v14030533","article-title":"Estimation of serial interval and reproduction number to quantify the transmissibility of SARS-CoV-2 omicron variant in South Korea","volume":"14","author":"Kim","year":"2022","journal-title":"Viruses"},{"key":"10.1016\/j.vaccine.2025.128167_bb0030","doi-asserted-by":"crossref","DOI":"10.1093\/cid\/ciae069","article-title":"Household transmission dynamics of asymptomatic SARS-CoV-2-infected children: a multinational, controlled case-ascertained prospective study","author":"Funk","year":"2024","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.vaccine.2025.128167_bb0035","doi-asserted-by":"crossref","first-page":"1239","DOI":"10.1001\/jama.2020.2648","article-title":"Characteristics of and important lessons from the coronavirus disease 2019 (COVID-19) outbreak in China: summary of a report of 72\u00a0314 cases from the Chinese Center for Disease Control and Prevention","volume":"323","author":"Wu","year":"2020","journal-title":"JAMA"},{"key":"10.1016\/j.vaccine.2025.128167_bb0040","doi-asserted-by":"crossref","first-page":"2603","DOI":"10.1056\/NEJMoa2034577","article-title":"Safety and efficacy of the BNT162b2 mRNA Covid-19 vaccine","volume":"383","author":"Polack","year":"2020","journal-title":"N Engl J Med"},{"key":"10.1016\/j.vaccine.2025.128167_bb0045","doi-asserted-by":"crossref","first-page":"384","DOI":"10.1001\/jamapediatrics.2022.6243","article-title":"Assessment of efficacy and safety of mRNA COVID-19 vaccines in children aged 5 to 11 years: a systematic review and meta-analysis","volume":"177","author":"Watanabe","year":"2023","journal-title":"JAMA Pediatr"},{"key":"10.1016\/j.vaccine.2025.128167_bb0050","doi-asserted-by":"crossref","first-page":"422","DOI":"10.15585\/mmwr.mm7111e1","article-title":"Effectiveness of 2-dose BNT162b2 (Pfizer BioNTech) mRNA vaccine in preventing SARS-CoV-2 infection among children aged 5\u201311 years and adolescents aged 12\u201315 years \u2013 PROTECT cohort, July 2021-February 2022","volume":"71","author":"Fowlkes","year":"2022","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"10.1016\/j.vaccine.2025.128167_bb0055","doi-asserted-by":"crossref","first-page":"352","DOI":"10.15585\/mmwr.mm7109e3","volume":"71","author":"Klein","year":"2022","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"10.1016\/j.vaccine.2025.128167_bb0060","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1016\/S2352-4642(23)00078-0","article-title":"Safety and effectiveness of vaccines against COVID-19 in children aged 5-11 years: a systematic review and meta-analysis","volume":"7","author":"Piechotta","year":"2023","journal-title":"Lancet Child Adolesc Health"},{"key":"10.1016\/j.vaccine.2025.128167_bb0065","doi-asserted-by":"crossref","first-page":"572","DOI":"10.1038\/s41586-021-03653-6","article-title":"BNT162b2 vaccine induces neutralizing antibodies and poly-specific T cells in humans","volume":"595","author":"Sahin","year":"2021","journal-title":"Nature"},{"key":"10.1016\/j.vaccine.2025.128167_bb0070","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1056\/NEJMoa2116298","article-title":"Evaluation of the BNT162b2 Covid-19 vaccine in children 5 to 11 years of age","volume":"386","author":"Walter","year":"2022","journal-title":"N Engl J Med"},{"key":"10.1016\/j.vaccine.2025.128167_bb0075","doi-asserted-by":"crossref","first-page":"621","DOI":"10.1056\/NEJMoa2211031","article-title":"Evaluation of BNT162b2 Covid-19 vaccine in children younger than 5 years of age","volume":"388","author":"Mu\u00f1oz","year":"2023","journal-title":"N Engl J Med"},{"key":"10.1016\/j.vaccine.2025.128167_bb0080","first-page":"249","article-title":"Self-reported real-world safety and reactogenicity of COVID-19 vaccines: a vaccine recipient survey","volume":"11","author":"Mathioudakis","year":"2021","journal-title":"Life (Basel)"},{"key":"10.1016\/j.vaccine.2025.128167_bb0085","doi-asserted-by":"crossref","first-page":"2794","DOI":"10.1016\/j.ymthe.2021.08.001","article-title":"A comprehensive analysis of the efficacy and safety of COVID-19 vaccines","volume":"29","author":"Cai","year":"2021","journal-title":"Mol Ther"},{"key":"10.1016\/j.vaccine.2025.128167_bb0090","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1016\/j.braindev.2009.09.019","article-title":"Current management of febrile seizures in Japan: an overview","volume":"32","author":"Sugai","year":"2010","journal-title":"Brain Dev"},{"key":"10.1016\/j.vaccine.2025.128167_bb0095","doi-asserted-by":"crossref","first-page":"7105","DOI":"10.1038\/s41467-021-27316-2","article-title":"A randomized study to evaluate safety and immunogenicity of the BNT162b2 COVID-19 vaccine in healthy Japanese adults","volume":"12","author":"Haranaka","year":"2021","journal-title":"Nat Commun"},{"key":"10.1016\/j.vaccine.2025.128167_bb0100","doi-asserted-by":"crossref","first-page":"1390","DOI":"10.1001\/jama.2021.15072","article-title":"Surveillance for adverse events after COVID-19 mRNA vaccination","volume":"326","author":"Klein","year":"2021","journal-title":"JAMA"},{"key":"10.1016\/j.vaccine.2025.128167_bb0105","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1001\/jama.2021.24110","article-title":"Myocarditis cases reported after mRNA-based COVID-19 vaccination in the US from December 2020 to august 2021","volume":"327","author":"Oster","year":"2022","journal-title":"JAMA"},{"key":"10.1016\/j.vaccine.2025.128167_bb0110","article-title":"Updated report of COVID-19 vaccine safety monitoring in Japan: booster shots and paediatric vaccinations","volume":"27","author":"Yamaguchi","year":"2022","journal-title":"Lancet Reg Health West Pac"},{"key":"10.1016\/j.vaccine.2025.128167_bb0115","article-title":"Updated report of COVID-19 vaccine safety monitoring in Japan: booster doses for omicron variants and vaccinations for infants and young children","volume":"38","author":"Yamaguchi","year":"2023","journal-title":"Lancet Reg Health West Pac"},{"key":"10.1016\/j.vaccine.2025.128167_bb0120","doi-asserted-by":"crossref","first-page":"773","DOI":"10.1016\/j.jiac.2024.02.020","article-title":"Safety and antibody response of the BNT162b2 SARS-CoV-2 vaccine in children aged 5-11 years with underlying diseases: a prospective observational study","volume":"30","author":"Funaki","year":"2024","journal-title":"J Infect Chemother"},{"key":"10.1016\/j.vaccine.2025.128167_bb0125","doi-asserted-by":"crossref","first-page":"42","DOI":"10.3390\/ijerph21010042","article-title":"Vaccine hesitancy and susceptibility to SARS-CoV-2 misinformation in Japanese youth: the contribution of personality traits and national identity","volume":"21","author":"Rivers","year":"2023","journal-title":"Int J Environ Res Public Health"},{"key":"10.1016\/j.vaccine.2025.128167_bb0130","article-title":"Safety monitoring of COVID-19 vaccines in Japan","volume":"23","author":"Yamaguchi","year":"2022","journal-title":"Lancet Reg Health West Pac"},{"key":"10.1016\/j.vaccine.2025.128167_bb0140","doi-asserted-by":"crossref","first-page":"702","DOI":"10.1093\/aje\/kwh090","article-title":"A modified Poisson regression approach to prospective studies with binary data","volume":"159","author":"Zou","year":"2004","journal-title":"Am J Epidemiol"},{"key":"10.1016\/j.vaccine.2025.128167_bb0145","doi-asserted-by":"crossref","first-page":"283","DOI":"10.15585\/mmwr.mm7008e3","article-title":"First month of COVID-19 vaccine safety monitoring \u2013 United States, December 14, 2020\u2013January 13, 2021","volume":"70","author":"Gee","year":"2021","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"10.1016\/j.vaccine.2025.128167_bb0150","doi-asserted-by":"crossref","DOI":"10.1542\/peds.2022-057508","article-title":"Risk of myopericarditis after COVID-19 vaccination in Danish children aged 5 to 11 years","volume":"150","author":"Nygaard","year":"2022","journal-title":"Pediatrics"},{"key":"10.1016\/j.vaccine.2025.128167_bb0155","doi-asserted-by":"crossref","DOI":"10.1001\/jamanetworkopen.2021.40364","article-title":"Analysis of COVID-19 vaccine type and adverse effects following vaccination","volume":"4","author":"Beatty","year":"2021","journal-title":"JAMA Netw Open"},{"key":"10.1016\/j.vaccine.2025.128167_bb0160","doi-asserted-by":"crossref","first-page":"534","DOI":"10.1002\/ajh.26132","article-title":"Thrombocytopenia following Pfizer and Moderna SARS-CoV-2 vaccination","volume":"96","author":"Lee","year":"2021","journal-title":"Am J Hematol"},{"key":"10.1016\/j.vaccine.2025.128167_bb0165","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1186\/s40249-021-00878-5","article-title":"Safety of SARS-CoV-2 vaccines: a systematic review and meta-analysis of randomized controlled trials","volume":"10","author":"Chen","year":"2021","journal-title":"Infect Dis Poverty"},{"key":"10.1016\/j.vaccine.2025.128167_bb0170","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1038\/s41586-020-2700-3","article-title":"Sex differences in immune responses that underlie COVID-19 disease outcomes","volume":"588","author":"Takahashi","year":"2020","journal-title":"Nature"},{"key":"10.1016\/j.vaccine.2025.128167_bb0175","doi-asserted-by":"crossref","first-page":"338","DOI":"10.1016\/S1473-3099(10)70049-9","article-title":"The Xs and Y of immune responses to viral vaccines","volume":"10","author":"Klein","year":"2010","journal-title":"Lancet Infect Dis"},{"key":"10.1016\/j.vaccine.2025.128167_bb0180","doi-asserted-by":"crossref","first-page":"1621","DOI":"10.3390\/vaccines11101621","article-title":"NEURO-COVAX: an Italian population-based study of neurological complications after COVID-19 vaccinations","volume":"11","author":"Salsone","year":"2023","journal-title":"Vaccines (Basel)"},{"key":"10.1016\/j.vaccine.2025.128167_bb0185","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1186\/s12916-022-02310-7","article-title":"Risk factors associated with short-term adverse events after SARS-CoV-2 vaccination in patients with immune-mediated inflammatory diseases","volume":"20","author":"Wieske","year":"2022","journal-title":"BMC Med"},{"key":"10.1016\/j.vaccine.2025.128167_bb0190","doi-asserted-by":"crossref","first-page":"1772","DOI":"10.3390\/vaccines11121772","article-title":"Sex differences in serious adverse events reported following booster doses of COVID-19 vaccination in Thailand: a countrywide nested unmatched case-control study","volume":"11","author":"Janekrongtham","year":"2023","journal-title":"Vaccines (Basel)"},{"key":"10.1016\/j.vaccine.2025.128167_bb0195","doi-asserted-by":"crossref","first-page":"E257","DOI":"10.1002\/ajh.26185","article-title":"Age-dependent and gender-dependent antibody responses against SARS-CoV-2 in health workers and octogenarians after vaccination with the BNT162b2 mRNA vaccine","volume":"96","author":"Terpos","year":"2021","journal-title":"Am J Hematol"},{"key":"10.1016\/j.vaccine.2025.128167_bb0200","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1542\/peds.2010-3318","article-title":"Neurodiagnostic evaluation of the child with a simple febrile seizure","volume":"127","year":"2011","journal-title":"Pediatrics"},{"key":"10.1016\/j.vaccine.2025.128167_bb0205","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1111\/bjh.17645","article-title":"Exacerbation of immune thrombocytopenia following COVID-19 vaccination","volume":"195","author":"Kuter","year":"2021","journal-title":"Br J Haematol"},{"key":"10.1016\/j.vaccine.2025.128167_bb0210","doi-asserted-by":"crossref","DOI":"10.1016\/j.isci.2021.103479","article-title":"The mRNA-LNP platform\u2019s lipid nanoparticle component used in preclinical vaccine studies is highly inflammatory","volume":"24","author":"Ndeupen","year":"2021","journal-title":"iScience"},{"key":"10.1016\/j.vaccine.2025.128167_bb0215","doi-asserted-by":"crossref","first-page":"46","DOI":"10.15585\/mmwr.mm7002e1","article-title":"Allergic reactions including anaphylaxis after receipt of the first dose of Pfizer-BioNTech COVID-19 vaccine \u2013 United States, December 14\u201323, 2020","volume":"70","author":"CDC COVID-19 Response Team, Food and Drug Administration","year":"2021","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"10.1016\/j.vaccine.2025.128167_bb0220","doi-asserted-by":"crossref","DOI":"10.1016\/j.heliyon.2024.e28337","article-title":"The effect of the coronavirus vaccinations on seizures in patients with epilepsy","volume":"10","author":"Delil","year":"2024","journal-title":"Heliyon"},{"key":"10.1016\/j.vaccine.2025.128167_bb0225","doi-asserted-by":"crossref","DOI":"10.1002\/jmv.29118","article-title":"Association of seizure with COVID-19 vaccines in persons with epilepsy: a systematic review and meta-analysis","volume":"95","author":"Rafati","year":"2023","journal-title":"J Med Virol"},{"key":"10.1016\/j.vaccine.2025.128167_bb0230","doi-asserted-by":"crossref","first-page":"702","DOI":"10.1016\/j.jinf.2022.10.015","article-title":"Germline variants of IGHV3-53 \/ V3-66 are determinants of antibody responses to the BNT162b2 mRNA COVID-19 vaccine","volume":"85","author":"Mashimo","year":"2022","journal-title":"J Infect"},{"key":"10.1016\/j.vaccine.2025.128167_bb0235","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2023.1217206","article-title":"Multi-phasic gene profiling using candidate gene approach predict the capacity of specific antibody production and maintenance following COVID-19 vaccination in Japanese population","volume":"14","author":"Takemoto","year":"2023","journal-title":"Front Immunol"},{"key":"10.1016\/j.vaccine.2025.128167_bb0240","doi-asserted-by":"crossref","first-page":"6991","DOI":"10.1016\/j.vaccine.2009.09.076","article-title":"Influence of cytokine gene variations on immunization to childhood vaccines","volume":"27","author":"Yucesoy","year":"2009","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2025.128167_bb0245","doi-asserted-by":"crossref","first-page":"256","DOI":"10.2152\/jmi.63.256","article-title":"Influence of single nucleotide polymorphisms of cytokine genes on anti-HBs antibody production after hepatitis B vaccination in a Japanese young adult population","volume":"63","author":"Yukimasa","year":"2016","journal-title":"J Med Invest"},{"key":"10.1016\/j.vaccine.2025.128167_bb0250","doi-asserted-by":"crossref","first-page":"306","DOI":"10.1016\/j.vaccine.2006.07.024","article-title":"Impact of genetic variants in IL-4, IL-4 RA and IL-13 on the anti-pneumococcal antibody response","volume":"25","author":"Wiertsema","year":"2007","journal-title":"Vaccine"}],"container-title":["Vaccine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X25014653?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X25014653?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,2,5]],"date-time":"2026-02-05T09:02:46Z","timestamp":1770282166000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0264410X25014653"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,2]]},"references-count":49,"alternative-id":["S0264410X25014653"],"URL":"https:\/\/doi.org\/10.1016\/j.vaccine.2025.128167","relation":{},"ISSN":["0264-410X"],"issn-type":[{"value":"0264-410X","type":"print"}],"subject":[],"published":{"date-parts":[[2026,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Adverse events post-BNT162b2 vaccination in Japanese children","name":"articletitle","label":"Article Title"},{"value":"Vaccine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.vaccine.2025.128167","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Elsevier Ltd. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"128167"}}